The number of Wegovy devices in a box depends on the presentation. The current U.S. prescribing information lists cartons containing four single-dose pens, four single-dose syringes, or one single-patient-use FlexTouch pen that delivers four weekly 2.4 mg doses. Saying that every Wegovy box contains four pens is therefore incomplete. Check the device type and strength on your own package before counting how many prescribed doses you have.
The same label also covers Wegovy tablets, which come in bottles rather than pen cartons. Package identification matters for refills, device training, storage, and avoiding a mismatch between the instructions you found online and the medicine you actually received.
The current U.S. package types at a glance
Section 16 of the reviewed label describes the injection presentations below. This is a packaging explanation, not an instruction to select a dose or substitute one device for another. Wegovy prescribing information, section 16.
| Presentation in the current U.S. label | Devices in a carton | What the package count means |
|---|---|---|
| Single-dose Wegovy pen | Four pens | Each pen is a single-dose device |
| Single-dose Wegovy syringe | Four syringes | Each syringe is a single-dose device |
| Wegovy FlexTouch single-patient-use pen | One pen | The listed pen contains four weekly 2.4 mg doses |
| Wegovy tablets | A bottle of 30 tablets | This is an oral product with a separate daily regimen |
Read the full label on the dispensed package. “One pen” can describe either a single-dose device or a device containing several doses, depending on the presentation. The words after the brand name provide important information.
A package listed in prescribing information is not a guarantee that every pharmacy has every presentation in stock. Ask the pharmacy which prescribed product it can dispense and whether the instructions will differ from your previous supply.
Why four devices and four doses are not always the same thing
A single-dose pen is used for one dose. A multidose, single-patient-use pen is a different device and may supply several scheduled doses for the same patient. You cannot determine the dose count from the visible number of objects alone.
For example, four individually packaged single-dose pens and one labeled four-dose pen have different device counts. That does not make their operating instructions interchangeable. It also does not authorize sharing a multidose pen or using the contents for an unprescribed amount.
Keep the device instructions that came with your medicine. Our Wegovy dosage guide discusses strengths and treatment schedules, while this article answers the packaging question. Both details need to match the prescription.
The current label identifies the FlexTouch presentation as containing four weekly 2.4 mg doses. Do not extend that statement to an assumed FlexTouch starter-dose schedule or an international product with different labeling.
Check the strength as well as the device count
A carton count says how many devices are packaged. The strength says how much semaglutide is associated with the labeled dose or presentation. These are separate pieces of information.
The current U.S. single-dose pen presentations include the labeled escalation strengths and a Wegovy HD presentation. A single-dose syringe range and the listed FlexTouch product have their own specifications. Read the exact prescribed strength instead of relying on a familiar box color. Wegovy label, sections 3 and 16.
Do not combine leftover devices, divide a single-dose device, or create a different dose from the carton count. If the strength on the box differs from your current prescription, clarify it with the pharmacy and prescriber before using it.
A higher total amount printed on a multidose package may describe the complete contents, rather than one weekly dose. Ask which label field identifies the dose your device delivers. You should not need an online conversion chart to reinterpret an unclear prescription.
What should you check when collecting the prescription?
Before leaving the pharmacy, compare the prescription and the package. A short check can prevent confusion later:
- Confirm the medicine name and whether it is injection or tablet.
- Confirm the strength and device presentation.
- Ask how many scheduled doses the dispensed quantity supplies.
- Confirm that the package includes the appropriate patient instructions.
- Ask whether any required administration supplies are included or must be obtained separately.
- Review storage and the next refill date.
This is especially useful after a pharmacy substitution between presentations or a planned treatment change. Tell the pharmacist if you have only been trained on a different device.
Keep the receipt and outer carton until the medication questions are resolved. Those records can help identify the exact product if the prescriber, pharmacy, or insurer needs to investigate a quantity issue.
How long does a box last?
For a weekly prescribed regimen, four scheduled weekly doses generally represent four weeks of planned treatment. That is a scheduling statement, not a promise about your next dose, insurance processing, or whether a change in treatment will occur.
A four-week supply is 28 days, whereas calendar months have different lengths. This can explain why a pharmacy’s days-supply field and a monthly budget do not always sound identical. Ask how the pharmacy submitted the particular prescription rather than assuming that every “month” is the same quantity.
Your prescriber may also change the plan because of tolerance, response, or another clinical issue. Do not assume the next refill must repeat the same strength just because the current carton has several devices remaining.
For oral Wegovy, use the separate daily tablet instructions and prescription quantity. The bottle count should not be interpreted through a weekly-injection schedule.
What if the pharmacy gives you only one pen?
First check whether it is the labeled four-dose FlexTouch presentation or an individually dispensed single-dose pen. The distinction changes the answer immediately.
Ask the pharmacy what quantity was prescribed, what was dispensed, and what days supply it represents. A partially filled prescription, an insurer’s quantity processing, and a different presentation require different follow-up. Do not assume an error or an adequate supply from the object count alone.
If the quantity does not support the prescribed schedule, contact the pharmacy before running out. Ask whether the rest of the fill is pending and what to do if you cannot obtain the next scheduled dose.
Our GLP-1 insurance coverage guide explains formulary and authorization questions. Coverage approval, pharmacy availability, and the number of doses dispensed remain separate facts.
Storage rules follow the exact presentation
The current label gives different storage instructions for single-dose devices and the FlexTouch presentation, including different allowances after specified storage or first-use conditions. Do not transfer a rule from one device to another. Wegovy label, section 16.
For single-dose pens and syringes, the label describes refrigerator storage and a limited permitted period outside refrigeration before cap removal. The multidose presentation includes its own after-first-use conditions. Use the supplied instructions, and ask the pharmacist about any temperature event or uncertainty.
Our semaglutide storage guide explains why brand, route, presentation, and compounded-product instructions must remain distinct. A delivery that arrived warm, a frozen device, or an unknown temperature history needs a product-specific response rather than a guess from another medicine’s window.
Write down the relevant first-use or storage date if the actual instructions require it. Avoid treating a date on the outer carton as the only handling limit that matters.
Do more doses in a pen mean different injection technique?
Different devices can have different preparation and use steps. Package count cannot teach those steps. Ask the pharmacy or prescribing team to demonstrate the exact device and use its Instructions for Use.
This article deliberately does not provide click-counting, dose-splitting, or device-modification directions. If you cannot confidently identify or operate the presentation you received, clarify it before the next administration.
If a dose may have been incompletely delivered or used incorrectly, record what happened and contact the care team. Our Wegovy injection-error guide explains why pain or device appearance alone cannot establish how much medicine was delivered. Do not automatically use a second device to compensate.
Plan a refill before the last scheduled dose
Keep track of doses actually used, the remaining prescribed supply, and the date the next dose is due. That provides a practical basis for a refill conversation.
Ask the pharmacy when the prescription can be processed and whether the next strength needs a separate order. If authorization is required, ask who will handle it and which documentation is missing. A carton count does not settle the administrative timeline.
Our Aetna Ozempic and Wegovy coverage guide illustrates why plan-specific benefit and authorization questions matter. Use your own insurer and plan details rather than borrowing another person’s coverage result.
If a supply gap occurs, ask the prescriber how to handle the missed dose or restart. The Wegovy stopping and restart guide can help organize those questions; it does not replace instructions for your own presentation and interruption.
Questions people commonly ask
Does every U.S. Wegovy box contain four pens?
No. The reviewed label also lists four single-dose syringes and one four-dose FlexTouch pen. Confirm the exact presentation. The oral product is supplied in bottles.
Is the FlexTouch pen a starter-dose pen?
The current U.S. presentation described here contains four weekly 2.4 mg doses. That statement does not establish suitability for initiation or authorize creating a smaller dose. Follow the prescribed product and schedule.
Can I use two lower-strength devices instead of one prescribed device?
Do not construct a replacement regimen from package arithmetic. Ask the prescriber and pharmacy about an appropriate prescribed supply if the intended strength is unavailable.
Are international Wegovy packages identical?
Do not assume so. This article describes the reviewed U.S. label. Check the locally supplied product information and prescribing instructions for medicine obtained through another country’s healthcare system.
Is a compounded semaglutide vial a Wegovy box?
No. It is a different product question. Our semaglutide vial guide addresses labels, concentrations, and pharmacy instructions. The CoreAge Rx semaglutide information page can help begin product questions without establishing that a dispensed preparation is branded Wegovy.
Count prescribed doses after identifying the product
Read the presentation and strength, confirm the quantity with the pharmacy, and keep the matching instructions. That resolves the real question—whether you have the correct supply for your prescription—more reliably than counting pens without checking what each device contains.
Educational information for adults; individual treatment decisions require a qualified clinician. Sources reviewed October 5, 2026. Original AI-generated article images depict fictional people and objects, not patient outcomes. Other editorial images are illustrative. Graphics summarize the cited sources.
